ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.81B
Enterprise Value 312.98B
Trailing P/E N/A
Forward P/E 1-29.59
PEG Ratio (5 yr expected) 1-0.48
Price/Sales (ttm)164.71
Price/Book (mrq)8.38
Enterprise Value/Revenue 3144.32
Enterprise Value/EBITDA 6-26.66

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-556.20%

Management Effectiveness

Return on Assets (ttm)-19.19%
Return on Equity (ttm)-36.54%

Income Statement

Revenue (ttm)89.91M
Revenue Per Share (ttm)0.99
Quarterly Revenue Growth (yoy)117.30%
Gross Profit (ttm)89.91M
EBITDA -486.72M
Net Income Avi to Common (ttm)-490.87M
Diluted EPS (ttm)-5.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.69B
Total Cash Per Share (mrq)16.93
Total Debt (mrq)30M
Total Debt/Equity (mrq)1.70
Current Ratio (mrq)12.23
Book Value Per Share (mrq)17.72

Cash Flow Statement

Operating Cash Flow (ttm)-382.79M
Levered Free Cash Flow (ttm)-325.27M

Trading Information

Stock Price History

Beta 3.27
52-Week Change 3175.23%
S&P500 52-Week Change 315.52%
52 Week High 3153.99
52 Week Low 346.90
50-Day Moving Average 3126.97
200-Day Moving Average 3122.18

Share Statistics

Avg Vol (3 month) 3823.49k
Avg Vol (10 day) 31.21M
Shares Outstanding 599.7M
Float 88.43M
% Held by Insiders 111.46%
% Held by Institutions 194.10%
Shares Short 36.11M
Short Ratio 34.39
Short % of Float 314.98%
Shares Short (prior month) 35.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A